Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Jan 2000

Koul Anjila, Bendahl P-O, Borg A, Fernö M, Lidebring M F, Högberg T, Einarsson E L, Ridderheim M, Willén R

Abstract excerpt

Mutations in the TP53 tumor suppressor gene have been shown to significantly correlate with poor prognosis in endometrial cancer. In the present study we have evaluated a luminometric immunoassay (LIA) for quantitative estimation of TP53 protein expression in 65 cytosol preparations from endometrial cancer, previously analyzed for mutations in TP53 exons 4-10. LIA showed high (> or = 0.6 ng/mg protein) expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunoassay

Share to Luminescent Proteins

Share to Neoplasm Staging

Share to Survival Analysis

Share to Sweden

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 12144684
DOI: 10.1046/j.1525-1438.2002.01111.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer.PMID 12144684Read ↗

Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols.Semantic proximity Read ↗

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survivalSemantic proximity Read ↗

Comparison of cytosolic p53 protein levels in the female genital tract and breast, and their tumors.Semantic proximity Read ↗

p53 genetic alterations, protein expression and autoantibodies in human colorectal carcinoma: A comparative study.Semantic proximity Read ↗

p53 protein overexpression in relation to risk factors for breast cancer.Semantic proximity Read ↗

Quantification and characterization of total cellular p53 protein in colorectal cancer.Semantic proximity Read ↗

Identification of TP53 gene mutations in uterine corpus cancer with short follow-up.Semantic proximity Read ↗

p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis.Semantic proximity Read ↗

Quantitative study on the correlation between p53 gene mutation and its expression in endometrial carcinoma cell lines.Semantic proximity Read ↗

Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma.Semantic proximity Read ↗

Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.Semantic proximity Read ↗

p53 Immunohistochemical Staining and TP53 Gene Mutations in Endometrial Cancer: Does Null Pattern Correlate With Prognosis?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.